Skip to main content

Antibiotic Adsorption on CRRT Membranes: Impact on Antibiotic Dosing

  • Chapter
Annual Update in Intensive Care and Emergency Medicine 2013

Abstract

Continuous renal replacement therapy (CRRT) is increasingly used in hemodynamically compromised or unstable patients with severe sepsis and septic shock. Adequate antimicrobial treatment is imperative and directly correlated with outcome in these patients. However, the pharmacokinetic behavior of most antibiotic agents during CRRT has not been investigated in depth. Antibiotics may be eliminated from the circulation by convection but also by adhering to the dialysis membrane itself, which may result in subtherapeutic plasma levels. In this context, the emergence of highly adsorptive dialysis membranes, such as the AN69 surface treated (AN69 ST) and the polymethylmetacrilate (PMMA) membranes among others, raises important questions related to antimicrobial therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chanard J, Lavaud S, Randoux C, Rieu P (2003) New insights in dialysis membrane biocompatibility: relevance of adsorption properties and heparin binding. Nephrol Dial Transplant 18:252–257

    Article  PubMed  CAS  Google Scholar 

  2. Randoux C, Gillery P, Georges N, Lavaud S, Chanard J (2001) Filtration of native and glycated beta2-microglobulin by charged and neutral dialysis membranes. Kidney Int 60:1571–1577

    Article  PubMed  CAS  Google Scholar 

  3. Hoenich NA, Stamp S (2000) Clinical performance of a new high-flux synthetic membrane. Am J Kidney Dis 36:345–352

    Article  PubMed  CAS  Google Scholar 

  4. Susla GM (2009) The impact of continuous renal replacement therapy on drug therapy. Clin Pharmacol Ther 86:562–565

    Article  PubMed  CAS  Google Scholar 

  5. Heintz BH, Matzke GR, Dager WE (2009) Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Pharmacotherapy 29:562–577

    Article  PubMed  CAS  Google Scholar 

  6. Kronfol NO, Lau AH, Barakat MM (1987) Aminoglycoside binding to polyacrylonitrile hemofilter membranes during continuous hemofiltration. ASAIO Trans 33:300–303

    PubMed  CAS  Google Scholar 

  7. Tian Q, Gomersall CD, Leung PP et al (2008) The adsorption of vancomycin by polyacrylonitrile, polyamide, and polysulfone hemofilters. Artif Organs 32:81–84

    PubMed  CAS  Google Scholar 

  8. Yumoto M, Nishida O, Moriyama K et al (2011)  In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration. Ther Apher Dial 15:385–393

    PubMed  CAS  Google Scholar 

  9. Choi G, Gomersall CD, Lipman J et al (2004) The effect of adsorption, filter material and point of dilution on antibiotic elimination by haemofiltration: an in vitro study of levofloxacin. Int J Antimicrob Agents 24:468–472

    PubMed  CAS  Google Scholar 

  10. Cigarran-Guldris S, Brier ME, Golper TA (1991) Tobramycin clearance during simulated continuous arteriovenous hemodialysis. Contrib Nephrol 93:120–123

    PubMed  CAS  Google Scholar 

  11. Kraft D, Lode H (1979) Elimination of ampicillin and gentamicin by hemofiltration. Klin Wochenschr 57:195–196

    Article  PubMed  CAS  Google Scholar 

  12. Tian Q, Gomersall CD, Ip M et al (2008) Adsorption of amikacin, a significant mechanism of elimination by hemofiltration. Antimicrob Agents Chemother 52:1009–1013

    Article  PubMed  CAS  Google Scholar 

  13. Tian Q, Gomersall CD, Ip M, Joynt GM (2011) Effect of preexposure to aminoglycosides on in vitro adsorption of amikacin by polyacrylonitrile hemofilters. Antimicrob Agents Chemother 55:3641–3642

    Article  PubMed  CAS  Google Scholar 

  14. Taccone FS, De Backer D, Laterre PF et al (2011) Pharmacokinetics of a loadingdose of amikacin in septic patients undergoing continuous renal replacement therapy. Int J Antimicrob Agents 37:531–535

    Article  PubMed  CAS  Google Scholar 

  15. GĂ¡lvez R, Luengo C, Cornejo R et al (2011) Higher than recommended amikacinloading doses achieve pharmacokinetic targets without associated toxicity. Int J Antimicrob Agents 38:146–151

    Article  PubMed  Google Scholar 

  16. Lam PKN, Tian Q, Ip M, Gomersall CD (2010) In vitro adsorption of gentamicin and netilmicin by polyacrylonitrile and polyamide hemofiltration filters. Antimicrob Agents Chemother 54:963–965

    Article  CAS  Google Scholar 

  17. Ikawa K, Morikawa N, Suyama H, Ikeda K, Yamanoue T (2009) Pharmacokinetics and pharmacodynamics of once-daily arbekacin during continuous venovenous hemodiafiltration in critically ill patients. J Infect Chemother 15:420–423

    Article  PubMed  CAS  Google Scholar 

  18. Spapen HD, Jacobs R, Van Gorp V, Troubleyn J, Honoré PM (2011) Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care 25:14

    Article  Google Scholar 

  19. Spapen HD, HonorĂ© PM, Gregoire N et al (2011) Convulsions and apnoea in a patient infected with New Delhi metallo-β-lactamase-1 Escherichia coli treated with colistin. J Infect 63:468–470

    Article  PubMed  Google Scholar 

  20. Marchand S, Frat JP, Petitpas F et al (2010) Removal of colistin during intermittent haemodialysis in two critically ill patients. J Antimicrob Chemother 65:1836–1837

    Article  PubMed  CAS  Google Scholar 

  21. Markou N, Fousteri M, Markantonis SL et al (2012) Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study. J Antimicrob Chemother 67:2459–2462

    Article  PubMed  CAS  Google Scholar 

  22. Honoré PM, Jacobs R, De Regt J, De Waele E, Van Gorp V, Spapen HD (2012) Membrane adsorption of colistin is becoming the major mechanism of elimination when using CRRT with enhanced adsorptive capacity haemofilters. Extensive pharmacokinetic evaluation about a case. Blood Purif 2012 (under review)

    Google Scholar 

  23. Dalfino L, Puntillo F, Mosca A et al (2012) High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study. Clin Infect Dis 54:1720–1726

    Article  PubMed  CAS  Google Scholar 

  24. Honoré PM, Jacobs R, Joannes-Boyau O, et al (2012) Newly designed CRRT membranes for sepsis and SIRS: a pragmatic approach for bedside intensivists summarizing the more recent advances. A systematic structured review. ASAIO Journal (in press)

    Google Scholar 

  25. Choi G, Gomersall CD, Tian Q, Joynt GM, Freebairn R, Lipman J (2009) Principles of antibacterial dosing in continuous renal replacement therapy. Crit Care Med 37:2268–2282

    Article  PubMed  CAS  Google Scholar 

  26. Shiraishi Y, Okajima M, Sai Y, Miyamoto K, Inaba H (2012) Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin. Anaesth Intensive Care 40:442–449

    PubMed  CAS  Google Scholar 

  27. Bellmann R, Falkensammer G, Seger C, Weiler S, Kountchev J, Joannidis M (2010) Teicoplanin pharmacokinetics in critically ill patients on continuous veno-venous hemofiltration. Int J Clin Pharmacol Ther 48:243–249

    PubMed  CAS  Google Scholar 

  28. Armendariz E, Chelluri L, Ptachcinski R (1990) Pharmacokinetics of amikacin during continuous veno-venous hemofiltration. Crit Care Med 18:675–676

    Article  PubMed  CAS  Google Scholar 

  29. Meyer B, TraunmĂ¼ller F, Hamwi A et al (2004) Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosage. Int J Clin Pharmacol Ther 42:556–560

    PubMed  CAS  Google Scholar 

  30. Wagner CC, Steiner I, Zeitlinger M (2009) Daptomycin elimination by CVVH in vitro: evaluation of factors influencing sieving and membrane adsorption. Int J Clin Pharmacol Ther 47:178–186

    PubMed  CAS  Google Scholar 

  31. Tian Q, Gomersall CD, Wong A et al (2006) Effect of drug concentration on adsorption of levofloxacin by polyacrylonitrile haemofilters. Int J Antimicrob Agents 28:147–150

    Article  PubMed  CAS  Google Scholar 

  32. Malone RS, Fish DN, Abraham E, Teitelbaum I (2001) Pharmacokinetics of levofloxacin and ciprofloxacin during continuous renal replacement therapy in critically ill patients. Antimicrob Agents Chemother 45:2949–2954

    Article  PubMed  CAS  Google Scholar 

  33. Bellmann R, Egger P, Gritsch W et al (2002) Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis. Acta Med Austriaca 29:112–116

    Article  PubMed  CAS  Google Scholar 

  34. Utrup TR, Mueller EW, Healy DP, Callcut RA, Peterson JD, Hurford WE (2010) High-dose ciprofloxacin for serious gram-negative infection in an obese, critically ill patient receiving continuous venovenous hemodiafiltration. Ann Pharmacother 44:1660–1664

    Article  PubMed  Google Scholar 

  35. Honoré PM, Jacobs R, Boer W et al (2012) New insights regarding rationale, therapeutic target and dose of hemofiltration and hybrid therapies in septic AKI. Blood Purif 33:44–51

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. M. Honoré .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Honoré, P.M., Jacobs, R., Spapen, H.D. (2013). Antibiotic Adsorption on CRRT Membranes: Impact on Antibiotic Dosing. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2013. Annual Update in Intensive Care and Emergency Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35109-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-35109-9_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-35108-2

  • Online ISBN: 978-3-642-35109-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics